Wirth, M. A., Becker, M. D., Graf, N., & Michels, S. (2016). Aflibercept in branch retinal vein occlusion as second line therapy: Clinical outcome 12 months after changing treatment from bevacizumab/ranibizumab—a pilot study. Int J Retina Vitreous.
Παραπομπή Chicago StyleWirth, Magdalena A., Matthias D. Becker, Nicole Graf, και Stephan Michels. "Aflibercept in Branch Retinal Vein Occlusion As Second Line Therapy: Clinical Outcome 12 months After Changing Treatment From Bevacizumab/ranibizumab—a Pilot Study." Int J Retina Vitreous 2016.
Παραπομπή MLAWirth, Magdalena A., Matthias D. Becker, Nicole Graf, και Stephan Michels. "Aflibercept in Branch Retinal Vein Occlusion As Second Line Therapy: Clinical Outcome 12 months After Changing Treatment From Bevacizumab/ranibizumab—a Pilot Study." Int J Retina Vitreous 2016.